MAPK3 and Alzheimer disease: The results of GO enrichment analysis demonstrated that anti-AD targets of CF are involved in multiple biological processes, such as inflammatory response, response to lipopolysaccharides, protein phosphorylation, positive regulation of ERK1 and ERK2 cascades, and negative regulation of the apoptotic process.